Pharmafile
Is the Current EU Legal Framework for Orphan Medicines Fit for Purpose?
Autumn 2019
Maria Isabel Manley, partner and head of the UK Global Life Sciences Practice, and Chris Boyle, associate, at Sidley, discuss the impact of regulatory frameworks on medicines for rare diseases.
Contacts
Capabilities
Suggested News & Insights
The EU AI Act’s Machinery Exemption: Does It Extend to Surgical Robotics?June 11, 2026Sidley Highly Ranked in Chambers USA 2026June 4, 2026Favorable Precision Oncology Advisory Opinion Imposes Limits on Supplemental Reports for PatientsJune 1, 2026Sidley Elects New Partnership Class of 52June 1, 2026Sidley Lawyers Joshua Hofheimer and Dino LaVerghetta to Speak at Doon Insights' Ag & Food Tech 13 WorkshopWednesday, May 27, 2026 - Thursday, May 28, 2026Sidley Represents Gilead in US$3 Billion Senior Unsecured Notes OfferingMay 20, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory